Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal …
C Zoccali, F Mallamaci, M Adamczak… - Cardiovascular …, 2023 - academic.oup.com
Chronic kidney disease (CKD) is classified into five stages with kidney failure being the most
severe stage (stage G5). CKD conveys a high risk for coronary artery disease, heart failure …
severe stage (stage G5). CKD conveys a high risk for coronary artery disease, heart failure …
[HTML][HTML] The effect of sodium-glucose co-transporter-2 (SGLT2) inhibitors on blood interleukin-6 concentration: a systematic review and meta-analysis of randomized …
Background The low-grade chronic inflammation in diabetes plays an important role in
development of cardiovascular and renal complications. Sodium-glucose co-transporter-2 …
development of cardiovascular and renal complications. Sodium-glucose co-transporter-2 …
Interleukin-6 and cardiovascular and kidney outcomes in patients with type 2 diabetes: new insights from CANVAS
OBJECTIVE The inflammatory cytokine interleukin-6 (IL-6) is associated with cardiovascular
(CV) and kidney outcomes in various populations. However, data in patients with type 2 …
(CV) and kidney outcomes in various populations. However, data in patients with type 2 …
[HTML][HTML] Butterfly pea flower (Clitoria ternatea L.) extract displayed antidiabetic effect through antioxidant, anti-inflammatory, lower hepatic GSK-3β, and pancreatic …
W Widowati, L Darsono, J Lucianus, E Setiabudi… - Journal of King Saud …, 2023 - Elsevier
Diabetes Mellitus (DM) is hyperglycemic or elevated blood glucose level and deficiency of
insulin level. DM treatment using synthetic drugs has several complexities, side effects …
insulin level. DM treatment using synthetic drugs has several complexities, side effects …
[HTML][HTML] Increased expression of circulating stress markers, inflammatory cytokines and decreased antioxidant level in diabetic nephropathy
G Mansoor, M Tahir, T Maqbool, SQ Abbasi, F Hadi… - Medicina, 2022 - mdpi.com
Background and Objectives: The main objective of the present study was to determine the
role of oxidative markers (glutathione (GSH), advanced oxidation protein products (AOPP) …
role of oxidative markers (glutathione (GSH), advanced oxidation protein products (AOPP) …
IL-38 in modulating hyperlipidemia and its related cardiovascular diseases
M Lai, H Peng, X Wu, X Chen, B Wang, X Su - International …, 2022 - Elsevier
Hyperlipidemia is confirmed to be associated with several health problems that include the
combination of diabetes mellitus, obesity, and hypertension, ie, metabolic syndrome …
combination of diabetes mellitus, obesity, and hypertension, ie, metabolic syndrome …
A wearable graphene transistor-based biosensor for monitoring IL-6 biomarker
Graphene-based field-effect transistor (GFET) is becoming an increasingly popular
biosensing platform for monitoring health conditions through biomarker detection. Moreover …
biosensing platform for monitoring health conditions through biomarker detection. Moreover …
Nephroprotective effects of honokiol in a high-fat diet-streptozotocin rat model of diabetic nephropathy
IA Rather, N Khan, AS Kushwah, G Surampalli… - Life Sciences, 2023 - Elsevier
Aims Diabetic nephropathy (DN) is the foremost basis of end-stage kidney failure implicating
endoplasmic reticulum (ER) stress and dysregulation of Rho kinase/Rock pathway …
endoplasmic reticulum (ER) stress and dysregulation of Rho kinase/Rock pathway …
[HTML][HTML] Diabetic complications and prospective immunotherapy
L Reynolds, Z Luo, K Singh - Frontiers in Immunology, 2023 - frontiersin.org
The incidence of Diabetes Mellitus is increasing globally. Individuals who have been
burdened with diabetes for many years often develop complications as a result of …
burdened with diabetes for many years often develop complications as a result of …
A pharmaceutical paradigm for cardiovascular composite risk assessment using novel radiogenomics risk predictors in precision explainable artificial intelligence …
Background: Cardiovascular disease (CVD) is challenging to diagnose and treat since
symptoms appear late during the progression of atherosclerosis. Conventional risk factors …
symptoms appear late during the progression of atherosclerosis. Conventional risk factors …